StonvexLoading…
StonvexStonvexStonvexCore line items from TXMD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2021 2021-09-30 | Annual 2021 2021-06-30 |
|---|---|---|---|---|
Revenue | $69.96M | $2.57M | $25.41M | $23.00M |
Operating Income | $1.19M | $-79.58M | $-39.92M | $-35.18M |
Net Income | $112.00M | $-172.41M | $-47.42M | $-42.65M |
EPS (Diluted) | $11.96 | $-21.66 | Not available | Not available |
Total Assets | $90.46M | $169.47M | Not available | Not available |
Total Liabilities | $55.31M | $263.09M | Not available | Not available |
Cash & Equivalents | $49.32M | $64.91M | Not available | Not available |
Free Cash Flow OCF − CapEx | Not available | $-142.73M | Not available | Not available |
Shares Outstanding | 9.50M | 8.60M | Not available | Not available |